{"version":"1.0","type":"link","title":"Therapeutic advances in HR+/HER2- advanced breast cancer after failure of CDK4/6 inhibitor therapy.","author_name":"Cui M 외","author_url":"https://prs-insight.online/author/Cui%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/81030","thumbnail_width":1200,"thumbnail_height":630}